Allurion Technologies, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

OTC.Pink
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.99% of Allurion Technologies, Inc.'s common stock as of March 31, 2025.
OTC.Pink
Leavitt Equity Partners and its affiliates have disclosed a beneficial ownership of 7.8% in Allurion Technologies, Inc., holding 462,762 shares of common stock.
OTC.Pink
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, reporting a shared beneficial ownership of 4.99% of Allurion Technologies, Inc.'s common stock as of January 31, 2025.